Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Salivary peptide fragment may be useful for oral candidiasis

Feb. 5, 1998

Favorable clinical safety, pharmacokinetics and anti-CMV activity reported for 1263W94

Feb. 5, 1998

Glaxo Wellcome characterizes in vitro/in vivo antibacterial activity of new trinem

Feb. 4, 1998

Shaman suspends phase II trial of Virend

Feb. 3, 1998

Trovan soon to be available in pharmacies

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

RiboGene and Dainippon join forces in antibacterial collaboration

Feb. 2, 1998

Roche discloses inhibitors of bacterial dihydrofolate reductase

Feb. 2, 1998

Complete efficacy reported for Viratrol in recurrent herpes labialis

Jan. 30, 1998

New antifungals reported by J&J subsidiary

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...